EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 335 filers reported holding EXELIXIS INC in Q4 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,713,922 | +3.5% | 106,853 | +1.2% | 0.20% | +8.3% |
| Q3 2022 | $1,656,000 | -61.8% | 105,590 | -55.6% | 0.18% | -53.2% |
| Q2 2021 | $4,336,000 | +200.1% | 237,968 | +230.4% | 0.38% | +256.5% |
| Q4 2020 | $1,445,000 | -33.3% | 72,022 | -21.0% | 0.11% | -45.2% |
| Q2 2020 | $2,165,000 | +61.8% | 91,199 | +20.1% | 0.20% | +146.2% |
| Q4 2019 | $1,338,000 | -18.7% | 75,939 | -18.4% | 0.08% | -13.0% |
| Q3 2019 | $1,645,000 | – | 93,010 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |